Article
Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Pathology oncology research : POR - 1 Jan 2017
Mátrai Zoltán, Andrikovics Hajnalka, Szilvási Anikó, Bors András, Kozma András, Ádám Emma, Halm Gabriella, Karászi Éva, Tordai Attila, Masszi Tamás
Abstract excerpt
The marked clinical heterogeneity of CLL makes early prognosis assessment important. Lipoprotein lipase (LPL) has been shown to confer adverse prognosis in CLL, recent data indicating it might also contribute to CLL cell survival and metabolism. We determined LPL mRNA expression in unselected peripheral blood of 84 CLL patients by RT PCR. Results were correlated with other prognostic markers and outcome. 30/84...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
